These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 27769114)
1. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies. Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114 [TBL] [Abstract][Full Text] [Related]
2. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer. Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790 [TBL] [Abstract][Full Text] [Related]
3. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea. Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219 [TBL] [Abstract][Full Text] [Related]
4. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
5. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients. Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076 [TBL] [Abstract][Full Text] [Related]
6. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer? Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933 [TBL] [Abstract][Full Text] [Related]
7. CT spectral parameters and serum tumour markers to differentiate histological types of cancer histology. Jia Y; Xiao X; Sun Q; Jiang H Clin Radiol; 2018 Dec; 73(12):1033-1040. PubMed ID: 30115364 [TBL] [Abstract][Full Text] [Related]
8. Progress and prospects of early detection in lung cancer. Blandin Knight S; Crosbie PA; Balata H; Chudziak J; Hussell T; Dive C Open Biol; 2017 Sep; 7(9):. PubMed ID: 28878044 [TBL] [Abstract][Full Text] [Related]
9. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers. Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480 [TBL] [Abstract][Full Text] [Related]
11. The diagnostic efficiency of seven autoantibodies in lung cancer. Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214 [TBL] [Abstract][Full Text] [Related]
15. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer. Zhao H; Zhang X; Han Z; Xie W; Yang W; Wei J Sci Rep; 2018 Jun; 8(1):9847. PubMed ID: 29959381 [TBL] [Abstract][Full Text] [Related]
16. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Farlow EC; Patel K; Basu S; Lee BS; Kim AW; Coon JS; Faber LP; Bonomi P; Liptay MJ; Borgia JA Clin Cancer Res; 2010 Jul; 16(13):3452-62. PubMed ID: 20570928 [TBL] [Abstract][Full Text] [Related]
17. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer. Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936 [TBL] [Abstract][Full Text] [Related]
19. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. Türeci O; Mack U; Luxemburger U; Heinen H; Krummenauer F; Sester M; Sester U; Sybrecht GW; Sahin U Cancer Lett; 2006 May; 236(1):64-71. PubMed ID: 15992994 [TBL] [Abstract][Full Text] [Related]
20. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]